The AiBharata Pulse
March 2026 Edition | AI + Healthcare Research Digest
Welcome to the inaugural edition of The AiBharata Pulse, your monthly digest of the latest research, trends, and breakthroughs in medical imaging AI and digital health. Whether you’re a radiologist, hospital administrator, or health-tech enthusiast, this newsletter keeps you current on what matters.
Medical Imaging AI: The Inflection Point Is Here
70% of Healthcare Organizations Now Use AI
The numbers tell the story: 70% of healthcare organizations are actively using AI, up from 63% in 2024, according to NVIDIA’s latest healthcare AI survey. AI has moved from experimental pilot programs into routine clinical use. Many hospitals now treat AI tools as core digital infrastructure within their imaging departments.
What’s changed? The conversation has shifted from “Should we adopt AI?” to “How do we measure the ROI of AI we’ve already deployed?” With over 1,000 AI-powered tools now FDA-cleared, the focus is squarely on efficiency, care coordination, and patient outcomes.
From Diagnosis to Prediction
The biggest conceptual shift in 2026 is the evolution of imaging from a purely diagnostic tool to a prognostic and predictive resource. Radiomics and machine learning approaches are already being used in oncology to:
- Forecast treatment response before therapy begins
- Predict recurrence risk from imaging biomarkers
- Enable precision dosing based on AI-identified molecular subgroups
One striking example: AI analysis of medulloblastoma cases identified specific molecular subgroups that allowed oncologists to administer precise treatment doses, significantly improving outcomes.
The Multimodal Future
Clinicians in 2026 are beginning to work with multimodal decision-support systems that combine medical scans with laboratory results, genomic data, pathology reports, and electronic health records into a single clinical picture. The scan is no longer a standalone artifact — it’s one layer in a rich diagnostic tapestry.
What this means for Myaira: Our AI Second Reader is designed exactly for this future. By providing AI-assisted analysis that flags findings and integrates with clinical context, we’re helping radiologists move from volume-based reading to value-based interpretation.
Medical Scan Sharing: The CD Is (Finally) Dying
Two-Thirds of Images Still Travel on Discs
Despite all the cloud innovation, a sobering statistic: an estimated two-thirds of radiological images are still shared via physical discs. CDs scratch, break, and fail. They can’t be accessed remotely. They’re a relic of the early 2000s that somehow persists in 2026.
But the tide is turning. Cloud-first platforms are rapidly replacing this workflow, and the market is consolidating. In February 2026, HealthMark Group acquired Purview, a cloud-based medical imaging company, signaling continued M&A activity in this space.
What Winning Platforms Look Like in 2026
The next generation of image sharing platforms share several characteristics:
- Cloud-first architecture with zero CD dependency
- AI-assisted workflow integration (not just storage, but intelligence)
- Secure cross-site sharing with HIPAA compliance, AES-256 encryption, and expiring links
- Access to priors — radiologists can see a patient’s imaging history, not just the current study
How Medixshare fits: This is precisely what we’ve built. Medixshare eliminates CDs, enables instant secure sharing via expiring links, and provides cloud-native access to scans from any device. No portal passwords. No disc drives. Just a link that works.
Online DICOM Viewers: The New Standard
Online DICOM viewers are becoming the default way clinicians interact with medical images. Key capabilities include:
- Browser-based viewing (no software installation)
- Multi-planar reconstruction and 3D rendering
- Mobile-responsive design for tablet and phone access
- Integration with AI analysis overlays
Diagnostic Breakthroughs: AI Gets Practical
Handheld Brain Injury Detection
A standout innovation: a handheld device that diagnoses hard-to-find brain injuries in 15 minutes using just a few drops of blood. It measures brain proteins down to the picogram level, enabling rapid triage in emergency settings without waiting for imaging.
AI-Powered Echocardiography
An AI-powered echocardiography platform is transforming cardiovascular care by integrating deep learning algorithms directly into ultrasound systems. The system automatically measures ejection fraction, strain, and other cardiac parameters that previously required expert manual analysis.
Cancer Detection: 93% Match Rate
AI diagnostic tools for cancer detection have reached a 93% match rate with expert tumor board recommendations. This isn’t about replacing oncologists — it’s about giving every patient access to expert-level analysis regardless of where they receive care.
Healthcare AI Moves Home
CES 2026 showcased a clear trend: healthcare technology is leaving the hospital. Wearables, smart scales, vision aids, and biometric trackers now use AI to translate raw data into actionable health insights. Early detection is becoming a daily activity, not a yearly checkup.
Regulatory Watch
EU AI Act Hits Radiology
By 2026, the EU AI Act requires radiology AI to meet “high-risk” compliance standards, including:
- Documenting training data curation processes
- Performing and disclosing bias checks
- Maintaining human oversight mechanisms
- Providing transparency on AI decision-making
This raises the compliance bar significantly. Companies like AiBharata that build with compliance-first architecture are well-positioned for this shift.
Speed of Obsolescence
A critical challenge: standalone AI models are becoming obsolete faster than health systems can deploy them. The procurement cycle for many hospitals now exceeds the useful life of a single-purpose AI tool. The solution? Platform-based approaches (like Myaira) that can update and add AI capabilities without full re-procurement.
By the Numbers
| Metric | 2024 | 2026 | Trend |
|---|---|---|---|
| Healthcare orgs using AI | 63% | 70% | Rising |
| FDA-cleared AI tools | ~700 | 1,000+ | Accelerating |
| Images shared via CD | ~70% | ~66% | Declining (slowly) |
| AI cancer detection accuracy | ~88% | 93% | Improving |
| AI drugs in clinical trials | 1 | 3+ | Growing |
What We’re Building
At AiBharata, we’re focused on two products that address these trends directly:
Medixshare — Instant, secure medical scan sharing that replaces CDs with encrypted, expiring links. Share any DICOM study with any clinician in seconds. HIPAA-compliant, zero-install, works on any device.
Myaira AI — An AI-powered second reader for radiology that flags findings, provides confidence scores, and integrates with clinical context. Designed to augment radiologists, not replace them.
Both products are built for the 2026 reality: cloud-first, AI-assisted, compliance-ready, and accessible from anywhere.
Subscribe
Want The AiBharata Pulse delivered to your inbox every month? Join our waitlist at aibharata.com to be the first to know about new features, research insights, and product updates.
The AiBharata Pulse is published monthly by AiBharata’s marketing team. For corrections or submissions, reach out via our contact page.